Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors

Clinical trial NCT00098514 · COMPLETED

Trial details

NCT number: NCT00098514
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-12-01
Primary completion: 2007-03-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.